Market revenue in 2023 | USD 86,850.7 million |
Market revenue in 2030 | USD 102,808.4 million |
Growth rate | 2.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Medical Microbiology & Cytology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 55.57% in 2023. Horizon Databook has segmented the North America clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
The North America market consists of U.S. and Canada. The region held the largest share of the global market in 2022, which can be attributed to the presence of a developed healthcare system and the increase in prevalence of chronic diseases in the region.
The presence of a well-established reimbursement framework for clinical laboratory services is another factor propelling the regional market. This creates an opportunity for market players in the region. Key players are focusing on improvised and software-enabled automated diagnosis systems and fully automated laboratories that help manage processing hundreds of samples at a time and obtaining accurate results.
The clinical trial laboratory services market was further boosted by the COVID-19 pandemic, which significantly increased the demand for clinical laboratory services. The coverage of COVID-19 tests under Medicare, Medicaid, and private insurance increased the number of clinical diagnoses in the region, which further bolstered the regional market.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America clinical laboratory service market , including forecasts for subscribers. This continent databook contains high-level insights into North America clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account